Terns Pharmaceuticals Cash Flow Statement 2019-2024 | TERN

Fifteen years of historical annual cash flow statements for Terns Pharmaceuticals (TERN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-90.21$-60.35$-50.16$-40.57$-68.82
$-4.15$1.11$1.39$0.43$0.16
$25.68$11.16$8.37$5.27$0.57
$21.53$12.27$9.76$5.70$0.73
$0$0$0$0$0
$0$0$0$0$0
$1.15$-0.72$1.73$-1.15$0.72
$-2.59$-1.73$0.22$1.43$-0.71
$1.29$-1.04$-1.43$5.06$1.87
$-67.39$-49.11$-41.83$-29.81$-66.22
$-0.05$-0.28$-0.34$-0.58$-0.90
$0$0$0$0$0
$0$0$0$0$0
$-37.94$-22.00$-119.36$7.28$-2.96
$0$0$0$0$0
$-37.94$-22.00$-119.36$7.28$-2.96
$0$0$0$0$0
$-37.99$-22.27$-119.70$6.69$-3.86
$0$0$136$0$0
$0$0$0$16.88$0.06
$0$0$136$16.88$0.06
$42.30$167$0.91$0.12$0.03
$42.30$167$0.91$69.50$0.03
$0$0$0$0$0
$-0.34$-0.40$-2.72$-0.86$-0.02
$41.95$167$134$85.52$0.06
$-63.31$95.54$-27.16$62.48$-70.15
$25.54$10.77$8.15$1.69$0.67
$0$0$0$0$0